CSL (ASX:CSL) has posted its half-year results, delivering results that are best described as mixed. At the headline level, ...

For thousands of Americans, donating plasma is a lifeline ... two-thirds of these centers are owned by one of three companies: CSL Plasma, Grifols, and BioLife. Even before the pandemic hit ...

Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...

Some of the bigger plasma donation centers include CSL Plasma, BioLife Plasma Services and Grifols Plasma. Durin Hendricks is a public relations associate in Washington, D.C., who donated plasma a ...

While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...

Reduction in CSL’s Plasma Supply Expected to be Short-Lived, Maintain AUD 282 FVE Plasma donations collected by narrow-moat CSL reduced in March, despite demand for its products increasing.

CSL (ASX: CSL) shares fell 4.9% on Tuesday following the company’s report of weaker-than-expected first-half revenue, net ...

which is now known as global biotechnology leader CSL Behring; US plasma collector Nabi, which helped to form the world’s premier plasma collection company in CSL Plasma; the Novartis influenza ...

Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business. Australia-based CSL, which runs a network of ...

CSL is one of three Tier 1 plasma therapy companies that benefit from an oligopoly in a highly consolidated market. All the players are vertically integrated as plasma sourcing is a key constraint ...